Sweden · Delayed Price · Currency is SEK BioGaia AB Statistics
Total Valuation
BioGaia AB has a market cap or net worth of SEK 12.31 billion. The enterprise value is 11.44 billion.
| Market Cap | 12.31B |
| Enterprise Value | 11.44B |
Important Dates
The next confirmed earnings date is Friday, July 17, 2026.
| Earnings Date | Jul 17, 2026 |
| Ex-Dividend Date | May 8, 2026 |
Share Statistics
BioGaia AB has 101.16 million shares outstanding. The number of shares has increased by 0.05% in one year.
| Current Share Class | 98.50M |
| Shares Outstanding | 101.16M |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.52% |
| Owned by Institutions (%) | 36.78% |
| Float | 84.12M |
Valuation Ratios
The trailing PE ratio is 37.11 and the forward PE ratio is 27.77.
| PE Ratio | 37.11 |
| Forward PE | 27.77 |
| PS Ratio | 7.97 |
| PB Ratio | 8.78 |
| P/TBV Ratio | 9.85 |
| P/FCF Ratio | 36.52 |
| P/OCF Ratio | 36.08 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.40, with an EV/FCF ratio of 33.94.
| EV / Earnings | 34.46 |
| EV / Sales | 7.41 |
| EV / EBITDA | 25.40 |
| EV / EBIT | 26.86 |
| EV / FCF | 33.94 |
Financial Position
The company has a current ratio of 4.94
| Current Ratio | 4.94 |
| Quick Ratio | 3.27 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 73.53 |
Financial Efficiency
Return on equity (ROE) is 20.87% and return on invested capital (ROIC) is 62.97%.
| Return on Equity (ROE) | 20.87% |
| Return on Assets (ROA) | 14.28% |
| Return on Invested Capital (ROIC) | 62.97% |
| Return on Capital Employed (ROCE) | 29.82% |
| Weighted Average Cost of Capital (WACC) | 5.92% |
| Revenue Per Employee | 6.36M |
| Profits Per Employee | 1.37M |
| Employee Count | 242 |
| Asset Turnover | 0.83 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BioGaia AB has paid 88.84 million in taxes.
| Income Tax | 88.84M |
| Effective Tax Rate | 21.11% |
Stock Price Statistics
The stock price has increased by +16.80% in the last 52 weeks. The beta is 0.30, so BioGaia AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +16.80% |
| 50-Day Moving Average | 123.81 |
| 200-Day Moving Average | 110.54 |
| Relative Strength Index (RSI) | 43.58 |
| Average Volume (20 Days) | 199,535 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioGaia AB had revenue of SEK 1.54 billion and earned 331.98 million in profits. Earnings per share was 3.28.
| Revenue | 1.54B |
| Gross Profit | 1.13B |
| Operating Income | 425.83M |
| Pretax Income | 420.81M |
| Net Income | 331.98M |
| EBITDA | 442.71M |
| EBIT | 425.83M |
| Earnings Per Share (EPS) | 3.28 |
Balance Sheet
The company has 871.78 million in cash and n/a in debt, with a net cash position of 871.78 million or 8.62 per share.
| Cash & Cash Equivalents | 871.78M |
| Total Debt | n/a |
| Net Cash | 871.78M |
| Net Cash Per Share | 8.62 |
| Equity (Book Value) | 1.40B |
| Book Value Per Share | 13.87 |
| Working Capital | 1.05B |
Cash Flow
In the last 12 months, operating cash flow was 341.20 million and capital expenditures -4.11 million, giving a free cash flow of 337.09 million.
| Operating Cash Flow | 341.20M |
| Capital Expenditures | -4.11M |
| Depreciation & Amortization | 16.88M |
| Net Borrowing | -6.76M |
| Free Cash Flow | 337.09M |
| FCF Per Share | 3.33 |
Margins
Gross margin is 72.97%, with operating and profit margins of 27.57% and 21.49%.
| Gross Margin | 72.97% |
| Operating Margin | 27.57% |
| Pretax Margin | 27.25% |
| Profit Margin | 21.49% |
| EBITDA Margin | 28.66% |
| EBIT Margin | 27.57% |
| FCF Margin | 21.83% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 3.21%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 3.21% |
| Dividend Growth (YoY) | -42.03% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 59.42% |
| Buyback Yield | -0.05% |
| Shareholder Yield | 3.17% |
| Earnings Yield | 2.70% |
| FCF Yield | 2.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.
| Last Split Date | May 18, 2022 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |